Post by Galderma

We are proud to share that Galderma has been selected for inclusion in the Swiss Market Index (SMI), Switzerland’s leading blue-chip equity index operated by SIX Swiss Exchange. The inclusion is expected to become effective in September. This marks an important milestone in Galderma’s journey as a publicly listed company following our IPO in March 2024. It reflects the strong progress we have made, the strength of our business, and our growing relevance in both the Swiss and global equity markets. As the pure-play dermatology leader, we remain focused on executing our Integrated Dermatology Strategy, advancing science-based innovation for patients and healthcare professionals, and creating sustainable long-term value for all our stakeholders. Thank you to our employees for their dedication and contributions to Galderma’s success, and to our shareholders, customers, and partners for their continued trust and support. #AdvancingDermatology #GALD